D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$625M |
| 3 |
Merck
MRK
|
+$498M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Fortinet
FTNT
|
+$321M |
Top Sells
| 1 |
Tesla
TSLA
|
+$696M |
| 2 |
Adobe
ADBE
|
+$610M |
| 3 |
Accenture
ACN
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$495M |
| 5 |
Broadcom
AVGO
|
+$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Root
ROOT
$1.54B
| $10.4M | 0.01% |
276,578
-135,579
| -33% | -$5.12M |
|
827
Assured Guaranty
AGO
$3.96B
| $10.4M | 0.01% |
131,359
+39,972
| +44% | +$3.18M |
|
828
Turning Point Brands
TPB
$1.81B
| $10.4M | 0.01% |
241,024
+5,345
| +2% | +$231K |
|
829
Anterix
ATEX
$405M
| $10.4M | 0.01% |
275,856
+197,970
| +254% | +$7.46M |
|
830
Y-mAbs Therapeutics
YMAB
$390M
| $10.4M | 0.01% |
787,536
-138,921
| -15% | -$1.83M |
|
|
USAR
831
USA Rare Earth, Inc. Class A Common Stock
USAR
$1.42B
| $10.4M | 0.01% |
963,823
+200,000
| +26% | +$2.15M |
|
832
Collegium Pharmaceutical
COLL
$1.23B
| $10.3M | 0.01% |
265,602
+66,739
| +34% | +$2.58M |
|
833
Upbound Group
UPBD
$1.48B
| $10.2M | 0.01% |
319,830
+185,915
| +139% | +$5.95M |
|
834
Ventas
VTR
$31.6B
| $10.2M | 0.01% |
159,132
+80,195
| +102% | +$5.14M |
|
835
NovoCure
NVCR
$1.42B
| $10.2M | 0.01% |
650,314
-48,980
| -7% | -$766K |
|
836
CompoSecure
CMPO
$1.97B
| $10.1M | 0.01% |
867,205
+656,404
| +311% | +$7.64M |
|
837
Century Communities
CCS
$2.06B
| $10.1M | 0.01% |
97,652
-15,792
| -14% | -$1.63M |
|
838
Gogo Inc
GOGO
$1.38B
| $10.1M | 0.01% |
1,400,071
-337,414
| -19% | -$2.42M |
|
839
Unilever
UL
$156B
| $10M | 0.01% |
+154,572
| New | +$10M |
|
|
RVNC
840
DELISTED
Revance Therapeutics, Inc.
RVNC
| $10M | 0.01% |
1,932,205
+1,824,225
| +1,689% | +$9.47M |
|
841
Canadian Imperial Bank of Commerce
CM
$73.9B
| $10M | 0.01% |
163,112
+106,312
| +187% | +$6.52M |
|
842
Pitney Bowes
PBI
$1.97B
| $10M | 0.01% |
1,402,750
-224,884
| -14% | -$1.6M |
|
843
StoneCo
STNE
$4.85B
| $9.96M | 0.01% |
884,241
-888,101
| -50% | -$10M |
|
844
REX American Resources
REX
$1.02B
| $9.93M | 0.01% |
214,452
-4,202
| -2% | -$195K |
|
845
Weave Communications
WEAV
$616M
| $9.9M | 0.01% |
773,536
-103,911
| -12% | -$1.33M |
|
846
Emerson Electric
EMR
$77.4B
| $9.89M | 0.01% |
90,435
-444,591
| -83% | -$48.6M |
|
847
AppFolio
APPF
$10.1B
| $9.87M | 0.01% |
41,937
-12,970
| -24% | -$3.05M |
|
848
Littelfuse
LFUS
$6.72B
| $9.84M | 0.01% |
37,091
-46,800
| -56% | -$12.4M |
|
849
UBS Group
UBS
$130B
| $9.81M | 0.01% |
317,247
+217,637
| +218% | +$6.73M |
|
850
Qualys
QLYS
$4.9B
| $9.8M | 0.01% |
76,280
-19,880
| -21% | -$2.55M |
|